2 of 3 innovative pharmas record operating profit ratio less than 10%
It was observed the innovative pharmaceutical companies’ operating profit ratio was weakened.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of 47 innovative pharmaceutical companies’ 2016 audit reports, their average operating profit ratio was 8.3%, decreased by 1.7%p compared...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
